Abstract
Feasibility of circulating tumor DNA as a marker for treatment response and prognosis in in BRCA non-mutated patients with platinum-sensitive recurrent ovarian cancer (OPEB-01) (011)
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
